ID: ALA2158423

Max Phase: Preclinical

Molecular Formula: C50H44N4O14S2

Molecular Weight: 989.05

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(=O)Nc1ccc(C(=O)N[C@]2(C(=O)O)[C@H](c3ccc(OC(=O)c4cccs4)c(OC)c3)[C@@](NC(=O)c3ccc(NC(=O)CC)cc3)(C(=O)O)[C@@H]2c2ccc(OC(=O)c3cccs3)c(OC)c2)cc1

Standard InChI:  InChI=1S/C50H44N4O14S2/c1-5-39(55)51-31-17-11-27(12-18-31)43(57)53-49(47(61)62)41(29-15-21-33(35(25-29)65-3)67-45(59)37-9-7-23-69-37)50(48(63)64,54-44(58)28-13-19-32(20-14-28)52-40(56)6-2)42(49)30-16-22-34(36(26-30)66-4)68-46(60)38-10-8-24-70-38/h7-26,41-42H,5-6H2,1-4H3,(H,51,55)(H,52,56)(H,53,57)(H,54,58)(H,61,62)(H,63,64)/t41-,42+,49+,50-

Standard InChI Key:  VPBGJWSJVWQQKE-ZCYAONDWSA-N

Associated Targets(non-human)

Glucagon-like peptide 1 receptor 331 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 989.05Molecular Weight (Monoisotopic): 988.2295AlogP: 7.35#Rotatable Bonds: 18
Polar Surface Area: 262.06Molecular Species: ACIDHBA: 14HBD: 6
#RO5 Violations: 4HBA (Lipinski): 18HBD (Lipinski): 6#RO5 Violations (Lipinski): 4
CX Acidic pKa: 2.58CX Basic pKa: CX LogP: 7.34CX LogD: 0.37
Aromatic Rings: 6Heavy Atoms: 70QED Weighted: 0.04Np Likeness Score: -0.47

References

1. Liu Q, Li N, Yuan Y, Lu H, Wu X, Zhou C, He M, Su H, Zhang M, Wang J, Wang B, Wang Y, Ma D, Ye Y, Weiss HC, Gesing ER, Liao J, Wang MW..  (2012)  Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor.,  55  (1): [PMID:22103243] [10.1021/jm201150j]

Source